Â鶹ѧÉú¾«Æ·°æ

Anna L. Parks
Rating: 5.0 of 5
( out of 80 reviews )

Anna L. Parks, MD

Languages spoken: English, Spanish

Clinical Locations

Sugar House Health Center

Salt Lake City
801-581-2000

  • Dr. Anna Parks is an Assistant Professor in the Division of Hematology & Hematologic Malignancies at the University of Utah and a faculty member of the Center on Aging. She specializes in non-malignant hematologic disorders, with a particular interest in thrombotic disorders. She is committed to providing compassionate, individualized care to each of her patients that emphasizes treating the disease and improving quality of life.

    Dr. Parks is dedicated to advancing the care of her patients through both clinical practice and research. Her research focuses on the intersection of aging and hematology, exploring how we can improve outcomes for older adults with blood disorders. Her work has been funded by the National Institutes of Health and the American Society of Hematology. Dr. Parks is also committed to teaching and mentoring the next generation of leaders in hematology.

    Dr. Parks graduated from Yale University. She received her medical degree, trained in Internal Medicine, served as a Chief Resident, and completed Hematology and Aging Research fellowships at the University of California, San Francisco. She grew up in Salt Lake City and is thrilled to be back. Outside of work, she enjoys cooking, reading fiction and hiking with her family.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)

    Patient Rating

    Rating: 5.0 out of 5
    5.0 /5
    ( out of 80 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    August 30, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr. Parks is very kind and she listened to what I had to say. She clearly explained a plan of action and treated me like a person who mattered.

    August 07, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Caring about her patients

    August 07, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr. Parks took spectacular care of me during my pregnancy and now beyond. My symptoms were new and scary to me, but I have felt all along as though I have been in excellent hands. She is obviously extremely sharp and knowledgeable and makes realistic suggestions and assertive treatment plans that help me feel secure. She has earned my utmost trust and respect and I am so glad she is my doctor.

    August 07, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Very Good

    August 04, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr. Anna Parks is excellent very professional, smart and very compasionate and caring provider.

    June 19, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr Parks is consistently excellent!

    June 12, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr. Park is knowledgeable courteous and polite. A physician of her caliber is difficult to find.

    May 28, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    The U of U Hemotology Dept. is fortunate to have Dr. Parks on their staff. She is a very caring, thoughtful, and knowledgeable physician. I would highly recommend her to anyone who is needing an outstanding physician.

    May 23, 2025
    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    One of the most caring doctors I have ever had. I am blessed to have her on my team. Thank you Dr Parks!

    See More Patient Comments

  • Dr. Anna Parks is an Assistant Professor in the Division of Hematology & Hematologic Malignancies at the University of Utah and a faculty member of the Center on Aging. She specializes in non-malignant hematologic disorders, with a particular interest in thrombotic disorders. She is committed to providing compassionate, individualized care to each of her patients that emphasizes treating the disease and improving quality of life.

    Dr. Parks is dedicated to advancing the care of her patients through both clinical practice and research. Her research focuses on the intersection of aging and hematology, exploring how we can improve outcomes for older adults with blood disorders. Her work has been funded by the National Institutes of Health and the American Society of Hematology. Dr. Parks is also committed to teaching and mentoring the next generation of leaders in hematology.

    Dr. Parks graduated from Yale University. She received her medical degree, trained in Internal Medicine, served as a Chief Resident, and completed Hematology and Aging Research fellowships at the University of California, San Francisco. She grew up in Salt Lake City and is thrilled to be back. Outside of work, she enjoys cooking, reading fiction and hiking with her family.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Assistant Professor (Clinical)
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)

    Education history

    Fellowship T32 Aging Research - University of California, San Francisco Fellow
    Fellowship Hematology and Oncology - University of California, San Francisco Fellow
    Residency Internal Medicine - University of California, San Francisco Chief Resident
    Residency Internal Medicine - University of California, San Francisco Resident
    Professional Medical Medicine - University of California, San Francisco School of Medicine M.D.
    Undergraduate History of Science & Medicine - Yale University B.A.

    Selected Publications

    Journal Article

    1. Parks AL, Slager SL, Cizik AM, Fang MC, Supiano MA, Katz PP, Witt DM (2025). The impact of anticoagulant-related bleeding on quality of life: Development of a novel measure based on perspectives from older adults. PLoS One, 20(1), e0316796. ()
    2. Parks AL, Stevens SM (2023). NSAIDs and hormonal contraceptives are linked to VTE in women with no previous thrombotic disease. Ann Intern Med, 176(12), JC143. ()
    3. Parks AL, Stevens SM (2023). In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation. Ann Intern Med. ()
    4. Parks AL, Fazili M, Aston V, Porter TF, Branch DW, Woller SC, Snow GL, Stevens SM (2023). Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound. Res Pract Thromb Haemost, 7(7), 102202. ()
    5. de Jong CMM, de Wit K, Black SA, Gwozdz AM, Masias C, Parks AL, Robert-Ebadi H, Talerico R, Woller SC, Klok FA (2023). Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease. J Thromb Haemost. ()
    6. Litt HK, Parks AL, Velazquez AI (2023). Blood Clots, or Thrombosis, in Patients With Cancer. JAMA Oncol. ()
    7. Fang MC, Reynolds K, Tabada GH, Prasad PA, Sung SH, Parks AL, Garcia E, Portugal C, Fan D, Pai AP, Go AS (2023). Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA Netw Open, 6(3), e232338. ()
    8. Fang MC, Go AS, Prasad PA, Zhou HX, Parks AL, Fan D, Portugal C, Sung SH, Reynolds K (2022). Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism. Thromb Res, 216, 97-102. ()
    9. Parks AL, Incze MA (2022). What Can At-home Genetic Tests Tell Me About My Health? JAMA Intern Med, 182(6), 691. ()
    10. Parks AL, Auerbach AD, Schnipper JL, Bertram A, Jeon SY, Boyle B, Fang MC, Gadrey SM, Siddiqui ZK, Brotman DJ, Hospital Medicine Reengineering Network HOMERuN (2022). Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals. PLoS One, 17(5), e0266944. ()
    11. Parks AL, Jeon SY, Boscardin WJ, Steinman MA, Smith AK, Covinsky KE, Fang MC, Shah SJ (2022). Long-term functional outcomes and mortality after hospitalization for extracranial hemorrhage. J Hosp Med, 17(4), 235-242. ()
    12. Cohen AB, Parks AL, Whitson HE, Zieman S, Brown CJ, Boyd C, Covinsky KE, Steinman MA (2020). Succeeding in Aging Research During the Pandemic: Strategies for Fellows and Junior Faculty. J Am Geriatr Soc, 69(1), 8-11. ()
    13. Parks AL, Auerbach AD, Schnipper JL, Anstey JE, Sterken DG, Hecht TEH, Fang MC, Hospital Medicine Reengineering Network HOMERuN (2020). COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic. Thromb Res, 196, 355-358. ()
    14. Parks AL, Fang MC (2017). Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding. Semin Thromb Hemost, 43(5), 514-524. ()
    15. Stern RJ, Parks AL (2016). Teaching High-Value Care on Rounds: Modeling Moderation. JAMA Intern Med, 176(2), 262-3. ()
    16. Parks AL, McWhirter RM, Evason K, Kelley RK (2015). Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy? J Gastrointest Cancer, 46(2), 161-5. ()
    17. Hammoud AO, Wilde N, Gibson M, Parks A, Carrell DT, Meikle AW (2008). Male obesity and alteration in sperm parameters. Fertil Steril, 90(6), 2222-5. ()

    Review

    1. Liu Y, Parks AL (2025). Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance: A Review. [Review]. JAMA Intern Med, 185(4), 450-456. ()
    2. Parks AL (2024). Anticoagulation at the end of life: whether, when, and how to treat. [Review]. Hematology Am Soc Hematol Educ Program, 2024(1), 348-354. ()
    3. Parks AL, Frankel DS, Kim DH, Ko D, Kramer DB, Lydston M, Fang MC, Shah SJ (2024). Management of atrial fibrillation in older adults. [Review]. BMJ, 386, e076246. ()
    4. Parks AL, Stevens SM, Woller SC (2024). Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations. [Review]. Thromb Res, 241, 109097. ()
    5. Parks AL, Fang MC (2023). Periprocedural Anticoagulation. [Review]. Ann Intern Med, 176(4), ITC49-ITC64. ()
    6. Parks AL, Fang MC (2016). Anticoagulation in Older Adults with Multimorbidity. [Review]. Clin Geriatr Med, 32(2), 331-46. ()

    Book Chapter

    1. Parks AL, Stevens S (). Hereditary Thrombophilias :Pathophysiology, Interpretation and Indications for Testing. In Syed A. Abutalib, M.D, Sangeetha Annaswamy (Eds.), Hoffman Textbook of Hematology (8). Spinger Nature.
    2. Parks AL, Andreadis C, Damon L (2021). Blood Disorders . In Papadakis M, McPhee S, Rabow M. (Eds.), Current Medical Diagnosis and Treatment (60th). McGraw Hill.

    Commentary

    1. Redberg RF, Parks AL, Rubin JB (2021). Persistent Gender Pay Gaps in Medicine: What Is Good for the Goose Is Better for the Gander's Paycheck. JAMA Intern Med, 181(9), 1164. ()
    2. Parks AL, Covinsky KE (2021). Anticoagulation at the End of Life: Time for a Rational Framework. JAMA Intern Med, 181(8), 1123. ()
    3. Parks AL, Kohlwes RJ (2017). Refining Risk for Deep Vein Thrombosis in Hospitalized Patients. J Gen Intern Med, 33(1), 6. ()
    4. Parks AL, Redberg RF (2017). Dabigatran Compared With Rivaroxaban vs Warfarin-Reply. JAMA Intern Med, 177(5), 744. ()
    5. Parks AL, Redberg RF (2016). Women in Medicine and Patient Outcomes: Equal Rights for Better Work? JAMA Intern Med, 177(2), 161. ()
    6. Parks AL, OMalley PG (2017). Applying Academic Detailing and Process Change to Promote Choosing Wisely-Reply. JAMA Intern Med, 177(2), 283. ()
    7. Parks AL, Redberg RF (2016). Comparing Non-Vitamin K Oral Anticoagulants: Where We Are Now. JAMA Intern Med, 176(11), 1672. ()
    8. Parks AL, OMalley PG (2016). From Choosing Wisely to Practicing Value-More to the Story. JAMA Intern Med, 176(10), 1571-1572. ()
    9. Parks AL, Covinsky KE (2016). Anticoagulation in the Very Old. JAMA Intern Med, 176(8), 1184. ()

    Case Report

    1. Han HJ, Parks AL, Shah MP, Hsu G, Santhosh L (2021). An Elusive Seizure. Neurohospitalist, 12(1), 188-194. ()

    Editorial

    1. Litt HK, Parks AL, Velazquez AI (). Blood Clots, or Thrombosis, in Patients with Cancer.
    2. Parks AL (2024). A sobering reminder and call to action: Preventing inpatient deaths from pulmonary emboli with a wraparound strategy. J Hosp Med. ()
    3. Incze MA, Parks AL, Stern RJ (2022). Teaching a Deeper Understanding of the Medical Literature. J Gen Intern Med, 38(4), 1-2. ()

    Abstract

    1. Brondfield S, Mulvey CK, Parks AL, et al (2021). Got Stage Fright? A Fellow-Led Initiative to Improve Cancer Staging Documentation.  [Abstract]. Int J Cancer.
    2. Parks AL, Kambhampati S, Fakhri B, Andreadis C, Gray L, Wong SW, Shah N, Fang MC (2020). Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma. [Abstract]. Leuk Lymphoma, 62(4), 1003-1006. ()
    3. Parks AL, Jeon SY, Boscardin WJ, Steinman MA, Smith AK, Fang MC, Shah SJ (2021). Long-term individual and population functional outcomes in older adults with atrial fibrillation. [Abstract]. J Am Geriatr Soc, 69, 1570-1578. ()

    Video/Film/CD/Web/Podcast

    1. Parks AL, Fang MC (2018). Web M&M: Isolated Clot, Real Error [Web]. Agency for Healthcare Research and Quality Patient Safety Network. Available: https://psnet.ahrq.gov/web-mm/isolated-clot-real-error.

  • News & Podcasts

    Huntsman Cancer Institute News